stars 1 stars 2 stars 3

Uquifa is a European leader in contract development and manufacturing for small molecules with a sharp focus on delivering high quality products with speed. With locations in North America and Europe, Uquifa is perfectly positioned to support customers with their New Chemical Entity programs, every step of the way, on their journey from pre-clinical to commercial. Uquifa’ sites have been successfully inspected and approved by major regulatory bodies, including US FDA, HEALTH CANADA, EMA, PMDA, KOREAN FDA, ANVISA and COFEPRIS. At Uquifa, our customers and partners are at the core of everything we do and our identity, ‘Uquifa, Chemistry for a better life’ sprouts not only from over 80 years of experience developing and manufacturing small molecules, but also from our strength in science brought to us by collaborations with thought leaders in the field of Chemistry. Uquifa also has a portfolio of Active Pharmaceutical Ingredients (APIs) available to our customers with over 150 active DMF´s filed and 26 COS approved.

UQUIFA Questions

The UQUIFA annual revenue was $191.5 million in 2026.

Saurabh Gurnurkar is the Managing Director of UQUIFA.

234 people are employed at UQUIFA.

The NAICS codes for UQUIFA are [32541, 325, 3254, 32].

The SIC codes for UQUIFA are [28, 283].

Top UQUIFA Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users